Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,780 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07032662

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Number - 1612 Tucson, Arizona, United States
  • Site Number - 1618 Carlsbad, California, United States
  • Site Number - 1619 Orange, California, United States
  • Site Number - 1607 Rancho Mirage, California, United States
View all 141 locations
View Trial Details
Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States
  • HIPS Washington D.C., District of Columbia, United States
  • CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States
  • Harm Reduction Sisters Duluth, Minnesota, United States
View Trial Details
Recruiting

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

NCT07673627

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations
  • Visionary Investigators Network Miami, Florida, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Dent Neurologic Institute - Amherst Amherst, New York, United States
View Trial Details
Recruiting

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

NCT06143514

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • PROVIDE Virtual Research Coordination Center San Francisco, California, United States
  • PROVIDE Virtual Research Coordination Center Smyrna, Georgia, United States
  • TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
  • PROVIDE Virtual Research Coordination Center Wilmington, North Carolina, United States
View Trial Details
Recruiting

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

NCT07086976

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Mayo Clinic in Arizona - Phoenix- Site Number : 8400032 Phoenix, Arizona, United States
  • Noble Clinical Research- Site Number : 8400003 Tucson, Arizona, United States
  • City of Hope National Medical Center- Site Number : 8400023 Duarte, California, United States
  • USC Norris Comprehensive Cancer Center- Site Number : 8400007 Los Angeles, California, United States
View all 95 locations
View Trial Details
Recruiting

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

NCT07503873

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • TG Therapeutics Investigational Trial Site Bihać, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Sarajevo, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Tuzla, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Zenica, Bosnia and Herzegovina
View all 39 locations
View Trial Details

Related conditions